🔎 Trials Near Me

Gara Jalqabaatti › Leukemia › Texas › Dallas

Qorannoo klinikaalii Leukemia Dallas, TX keessatti

Qorannoo 8 Leukemia f Dallas fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Namoota walitti qabaa jiraSadarkaa 3
  • Texas Oncology-Presbyterian Cancer Center, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT06001788

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Namoota walitti qabaa jiraSadarkaa 2
  • University of Texas, Southwestern, Dallas
Umuriin 7 hanga 25 · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT05082519

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Namoota walitti qabaa jiraQorannoo ilaalaa
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Umuriin hundi · Saalaa hunda · Haaromfame 18-Cam-2026 · NCT01790152

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Namoota walitti qabaa jiraSadarkaa 2/3
  • University of Texas Southwestern Medical Center, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Elb-2026 · NCT04256317

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Texas(UT) Southwestern-Children's Medical Center, Dallas
Umuriin 12 hanga 95 · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT04329728

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Namoota walitti qabaa jiraSadarkaa 1
  • UT Southwestern - Simmons Cancer Center, Dallas
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT05735184

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Dallas
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Qorannoo Leukemia magaalota biroo keessatti

Qorannoo biroo Dallas keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.